Supreme Court Temporarily Restores Mifepristone Mail Access
Justice Samuel Alito’s order keeps telehealth, pharmacy and mail access in place for a week while the court weighs emergency appeals.
- On Monday, Supreme Court Justice Samuel Alito issued a temporary administrative stay restoring nationwide telehealth, pharmacy, and mail access to mifepristone, blocking a Fifth Circuit ruling until May 11, 2026.
- Louisiana officials sued the Food and Drug Administration to restrict mifepristone, arguing telehealth prescribing undermines the state's abortion ban; the Fifth Circuit panel blocked the 2023 rule on May 1.
- Danco Laboratories and GenBioPro filed emergency appeals, warning the Fifth Circuit's decision injected "immediate confusion and upheaval" into time-sensitive medical decisions and urging the high court to pause the lower court's order.
- Reproductive rights advocates welcomed the stay, though legal groups warned the underlying threat persists; anti-abortion group Students for Life President Kristan Hawkins alleged the decision allows "pill traffickers" to operate.
- Justice Alito set an accelerated schedule requiring parties to file briefs by Thursday, May 7, with the administrative stay remaining in effect until May 11 while the court weighs federal versus state distribution authority.
234 Articles
234 Articles
The dispatch of Mifepriston, a medicine for abortion, is permitted for the time being. The Supreme Court lifted the restriction of an appeal court.
(Washington = Yonhap News) Correspondent Hong Jeong-gyu = On the 4th (local time), the U.S. Supreme Court... regarding the mail-order prescription of 'oral abortion pills' widely used in the United States...
Access To Abortion Pill By Mail Temporarily Restored By Supreme Court * 100PercentFedUp.com * by Danielle
The Supreme Court on Monday temporarily restored broad access to the abortion pill mifepristone by mail. Two companies that manufacture mifepristone asked the high court to “pause a ruling by the U.S. Court of Appeals for the 5th Circuit in a lawsuit by Louisiana that reinstated the requirement that the drug, which is used in about 60% of abortions nationwide, be dispensed only in person,” SCOTUSblog reports. The order signed by Justice Samuel A…
Coverage Details
Bias Distribution
- 44% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium








































